Ophthalmology Search
Ophthalmology Ophthalmology
blepharitis
BLEPHARITIS
Blepharitis is an inflammation process affecting the eyelid margins, eyelash follicles or openings of the anteriorly-placed accessory lacrimal glands and the posteriorly-placed Meibomian glands that causes ocular irritation and redness acutely but usually chronically.
It may have periods of exacerbations and remissions.
It usually occurs in middle-aged adults but can also start in childhood.
Can affect vision by disrupting the surface of the cornea and the bulbar conjunctiva; may influence tear film composition.
Drug Information

Indication: Purulent bacterial & trachomatous conjunctivitis caused by Chlamydia trachomatis in adults & childn fr...

Indication: Ophth Conjunctivitis, corneal injuries, superficial punctuate keratitis, vernal keratoconjunctivitis. Adjunct ...

Indication: Ocular infections involving conjunctiva &/or cornea due to susceptible organisms.

Indication: Bacterial conjunctivitis.

Indication: Local treatment for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated ...

Indication: Bacterial eye infections caused by susceptible organisms in conjunctivitis, blepharitis, sty, keratitis, dacry...

Indication: Ocular infections involving conjunctiva &/or cornea caused by chlorampenicol-susceptible organisms

Indication: Fungal blepharitis, conjunctivitis & keratitis caused by susceptible organisms.

Neo-Deca
dexamethasone sodium phosphate + neomycin sulfate

Indication: Acute steroid-responsive inflammatory & allergic conditions w/ accompanying bacterial infections.

Indication: Ophth infections.

1  /  4
1  /  4
Editor's Recommendations
Most Read Articles
Beta-blockers may reduce mortality in patients with heart failure, renal dysfunction
Roshini Claire Anthony, 6 days ago

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.
Reducing risks and improving long-term outcomes in patients with CHB
Prof. Vincent Wong, Prof. Ray Kim, Dr. Tan Poh Seng, 10 Sep 2019
Chronic hepatitis B (CHB) remains a major public health concern because of its worldwide distribution and potential adverse sequelae, including cirrhosis and hepatocellular carcinoma (HCC). At a recent symposium held during the GIHep Singapore 2019, Professor Vincent Wong from the Chinese University of Hong Kong and Professor Ray Kim from the Stanford University School of Medicine, Stanford, California, US, discussed antiviral treatments for CHB, with a focus on the novel agent tenofovir alafenamide (Vemlidy®). Dr Tan Poh Seng from the National University Hospital, Singapore, chaired the symposium.
Early-life exposures affect BP in children
11 Sep 2019
Blood pressure (BP) in children is influenced by early-life exposure to several chemicals, built environment and meteorological factors, suggests a study.
UTI risk not raised with SGLT-2is in real-world study
Pearl Toh, 18 hours ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.